Summary
Boston Scientific Corporation (BSX) filed an 8-K on April 19, 2012, to announce its financial results for the first quarter ended March 31, 2012. The primary purpose of this filing was to furnish a press release detailing these results. Investors should note that the information provided in this Item 2.02 and its accompanying exhibit is not considered 'filed' under Section 18 of the Exchange Act, meaning it does not carry the same regulatory implications as a formally filed document. This is a common practice for earnings releases furnished via 8-K. The actual financial performance details are contained within the press release itself (Exhibit 99.1), which is incorporated by reference. While the 8-K itself is brief and procedural, the furnished press release (Exhibit 99.1) would contain the crucial figures and commentary regarding revenue, profitability, segment performance, and any forward-looking statements or guidance provided by management. Investors should refer to this exhibit for a comprehensive understanding of BSX's Q1 2012 performance and outlook. The filing serves as official notification of the release of these results.
Key Highlights
- 1Boston Scientific Corporation (BSX) announced its Q1 2012 financial results via an 8-K filing on April 19, 2012.
- 2The filing primarily furnished a press release (Exhibit 99.1) containing the detailed financial results for the quarter ended March 31, 2012.
- 3Information in Item 2.02 and Exhibit 99.1 is furnished, not filed, and is not subject to Section 18 of the Exchange Act.
- 4Investors should consult the press release (Exhibit 99.1) for specific financial metrics, performance commentary, and outlook.
- 5The 8-K serves as formal notification of the earnings release to the market.
- 6No new material agreements or significant corporate events beyond the earnings announcement were reported in this specific 8-K.